Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination
-
Kratos Defense & Security Solutions, Inc. Announces Completion of Public Offering of $575 Million of Common Stock at $38.50 Per Share
-
Apollo Announces Olympus Housing Capital
-
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement
-
Amaero Appoints Brett Paduch as Chief Financial Officer
-
Catheter Precision, Inc. Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform
-
Heartflow to Showcase Landmark DECIDE Data at SCCT 2025, Advancing AI-Driven Care for Coronary Artery Disease
-
Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China
-
Spectral AI Announces Submission to FDA of its DeepView® System
-
Transom-Backed Secur-Serv Completes Fifth Add-On Acquisition, Delivers M&A Growth Story
-
Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live’25
-
HealthLynked Appoints Andrew Mavliev as Chief Technology and Product Officer to Accelerate Direct-to-Consumer Healthcare Innovation
-
Tectonic Therapeutic Joins Russell 3000® Index
-
Freshworks Launches Freshservice Journeys to Make Work Life Easier by Removing Frustration from Employee Experiences
-
Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179
-
SPR Receives Fourth Consecutive Northeast Ohio Top Workplaces Award
-
Protara Therapeutics Announces Addition to the Russell 3000® Index
-
Synergy CHC Corp. (NASDAQ: SNYR) Secures Landmark Retail and Distribution Wins Across North America for FOCUSfactor Supplements and Functional Beverages
-
IMUNON Submits Plan in Consultation with the Exchange to Ensure Compliance with Nasdaq’s Listing Requirement, Anticipates Additional Compliance Period
-
Great Lakes Announces Receipt of Four Dredging Awards including Woodside Louisiana LNG
-
Redwood Logistics Showcases OTM, WMS & GTM Integrations at Oracle OTM SIG 2025
-
Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions
-
Gentex Schedules Second Quarter 2025 Earnings Release Date and Conference Call
-
Richtech Robotics Joint Venture Partner Secures $4M Sales Agreement to Expand Reach in Asia’s AI Robotics Market
-
Cuprina Provides Update on Research Studies with Three Leading Education Institutes
-
BitMEX Study Reveals 90% Drop in Extreme Bitcoin Perpetual Futures Funding Rates Since 2016, Signalling Market Maturation
-
LogicFlo raises $2.7M to arm every life sciences expert with their own AI workforce
-
Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic
-
ASML reports transactions under its current share buyback program
-
Bonx raises $8.6 million to champion European manufacturing with market-leading AI ERP
-
JDE Peet’s share buyback periodic update June 30, 2025
-
Form 8.3 - [MARLOWE PLC - 27 06 2025] - (CGWL)
-
Ringkjøbing Landbobank issues Tier 2 capital
-
Form 8.3 - Marlowe plc - Octopus Investments
-
Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain
-
Form 8.3 - [MARLOWE PLC - 26 06 2025] - (CGWL) ** CORRECTED **
-
Topicus.com Inc. successfully completes inaugural €200 million Schuldschein loan
-
Diginex’s AI-Driven Enhancements Poised to Accelerate Customer Adoption and Drive Revenue Growth
-
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy
-
Banking and Payments Expert Joins FTI Consulting as Senior Managing Director
-
Palvella Therapeutics Added to Russell 3000® and Russell 2000® Indexes
-
Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
-
Bimergen Energy Enhances Shareholder Value by Canceling 25.1% of Its Outstanding Common Stock
-
INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease
-
BridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European Royalty
-
Abeona Therapeutics® added to Membership of U.S. Small-cap Russell 2000® Index and Broad-market Russell 3000® Index
-
Chart Industries to Announce Second Quarter 2025 Results on July 31
-
Marex Group plc added to membership of Russell 3000® Index
-
FOXO TECHNOLOGIES INC.’S BEHAVIORAL HEALTH SUBSIDIARY HAS BEEN APPROVED TO RECEIVE SCOTT COUNTY OPIOID ABATEMENT FUNDS
-
Transactions in connection with share buyback programme
